Maura Gallo
Research Subjects
Research Interests
Maura Gallo has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Francesca Frangipane
Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy
12 shared publicationsGianfranco Puccio
Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy
12 shared publicationsMaria Mirabelli
Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy
12 shared publicationsSilvana Geracitano
Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy
12 shared publicationsCarmine Tomaino
Regional Neurogenetic Centre, ASP Catanzaro, Lamezia Terme (CZ), Italy
11 shared publicationsRaffaele Maletta
Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy
10 shared publications
Latest Publications
- 1 December 2012
- Published by Elsevier in Neurobiology of Aging
- Vol. 33 (12) , 2948.e1-2948.e10
Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in Southern Italy
- 1 December 2012
- Published by Elsevier in Neurobiology of Aging
- Vol. 33 (12) , 2948.e1-2948.e10
Epidemiology and genetics of frontotemporal dementia: a door-to-door survey in Southern Italy
- 3 February 2011
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (4) , 757.e1-757.e11
Compound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia
- 3 February 2011
- Published by Elsevier in Neurobiology of Aging
- Vol. 32 (4) , 757.e1-757.e11
Compound heterozygosity of 2 novel MAPT mutations in frontotemporal dementia
- 1 January 2011
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 25 (1) , 96-99
MAPT V363I Variation in a Sporadic Case of Frontotemporal Dementia
The V363I mutation of the microtubule-associated protein tau gene has previously been associated with a case of primary progressive nonfluent aphasia with variable penetrance. Herein, we report the finding of the V363I variation in a sporadic early onset frontotemporal dementia patient and in several members of her family. The V363I variation was associated with frontotemporal dementia only in the proband which was also homozygous for the A allele of the progranulin single-nucleotide polymorphism rs9897526 and for methionine at codon 129 of the prion protein gene. The microtubule-associated protein tau V363I variation could be considered either an incomplete penetrant mutation or a rare polymorphism; although its pathogenicity has yet to be clearly demonstrated, modifier genetic factors seem to contribute to the pathogenic effects observed in the patient underlining the great complexity existing in neurodegenerative diseases and questioning so-called sporadic cases that can potentially be caused by gene mutation.
- 1 January 2011
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 25 (1) , 96-99
MAPT V363I Variation in a Sporadic Case of Frontotemporal Dementia
The V363I mutation of the microtubule-associated protein tau gene has previously been associated with a case of primary progressive nonfluent aphasia with variable penetrance. Herein, we report the finding of the V363I variation in a sporadic early onset frontotemporal dementia patient and in several members of her family. The V363I variation was associated with frontotemporal dementia only in the proband which was also homozygous for the A allele of the progranulin single-nucleotide polymorphism rs9897526 and for methionine at codon 129 of the prion protein gene. The microtubule-associated protein tau V363I variation could be considered either an incomplete penetrant mutation or a rare polymorphism; although its pathogenicity has yet to be clearly demonstrated, modifier genetic factors seem to contribute to the pathogenic effects observed in the patient underlining the great complexity existing in neurodegenerative diseases and questioning so-called sporadic cases that can potentially be caused by gene mutation.
- 1 November 2009
- Published by Elsevier in Neurobiology of Aging
- Vol. 30 (11) , 1825-1833
Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia
- 1 November 2009
- Published by Elsevier in Neurobiology of Aging
- Vol. 30 (11) , 1825-1833
Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia
- 19 September 2009
- Published by Springer Nature in Neurological Sciences
- Vol. 31 (1) , 65-70
Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia
A clinical and molecular overlap between Alzheimer’s disease (AD) and frontotemporal dementia (FTD) has been reported. Presenilins have been associated with FTD or with FTD-like phenotype, while mutations in the MAPT gene have been linked to a clinical phenotype of AD. We performed a clinical and genetic examination in two FTD siblings and their family tree has been reconstructed. We identified a novel Val75Ala MAPT mutation in one patient and in the other the Arg62His Presenilin2 mutation. The DNA variations identified, defined mutations by frequency, per se are not causative of the disease. These mutations, possibly in association with other unknown environmental and genetic factors, may contribute to neurodegeneration. In this family, the disease might result from a genetically interconnected spectrum of altered pathways that could link most neurodegenerative disorders. Moreover, the novel mutation identified merits further functional studies that would contribute to the unravelling of such a complex field.
- 19 September 2009
- Published by Springer Nature in Neurological Sciences
- Vol. 31 (1) , 65-70
Novel MAPT Val75Ala mutation and PSEN2 Arg62Hys in two siblings with frontotemporal dementia
A clinical and molecular overlap between Alzheimer’s disease (AD) and frontotemporal dementia (FTD) has been reported. Presenilins have been associated with FTD or with FTD-like phenotype, while mutations in the MAPT gene have been linked to a clinical phenotype of AD. We performed a clinical and genetic examination in two FTD siblings and their family tree has been reconstructed. We identified a novel Val75Ala MAPT mutation in one patient and in the other the Arg62His Presenilin2 mutation. The DNA variations identified, defined mutations by frequency, per se are not causative of the disease. These mutations, possibly in association with other unknown environmental and genetic factors, may contribute to neurodegeneration. In this family, the disease might result from a genetically interconnected spectrum of altered pathways that could link most neurodegenerative disorders. Moreover, the novel mutation identified merits further functional studies that would contribute to the unravelling of such a complex field.
- 1 July 2009
- Published by Wiley in Alzheimer's & Dementia
- Vol. 5 (4S_Part_13)
P3‐166: Epidemiology of Frontotemporal dementia in southern Italy
- 1 July 2009
- Published by Wiley in Alzheimer's & Dementia
- Vol. 5 (4S_Part_13)
P3‐166: Epidemiology of Frontotemporal dementia in southern Italy
- 1 July 2008
- Published by Wiley in Alzheimer's & Dementia
- Vol. 4 (4S_Part_18) , T606
P3‐286: Subcortical ischemic vascular dementia: A search for APP gene mutations
- 1 July 2008
- Published by Wiley in Alzheimer's & Dementia
- Vol. 4 (4S_Part_18) , T606
P3‐286: Subcortical ischemic vascular dementia: A search for APP gene mutations
- 1 July 2008
- Published by Wiley in Alzheimer's & Dementia
- Vol. 4 (4S_Part_18)
P3‐279: A novel progranulin mutation in a large frontotemporal dementia calabrian kindred
- 1 July 2008
- Published by Wiley in Alzheimer's & Dementia
- Vol. 4 (4S_Part_18)
P3‐279: A novel progranulin mutation in a large frontotemporal dementia calabrian kindred
- 1 July 2008
- Published by Wiley in Alzheimer's & Dementia
- Vol. 4 (4S_Part_18) , T603
P3‐277: TAU V363I mutation: Pathogenic or not?
- 1 July 2008
- Published by Wiley in Alzheimer's & Dementia
- Vol. 4 (4S_Part_18) , T603
P3‐277: TAU V363I mutation: Pathogenic or not?
- 7 March 2007
- Published by Springer Nature in Journal of Neurology
- Vol. 254 (3) , 391-393
Presenilin 2 Ser130Leu mutation in a case of late-onset “sporadic” Alzheimer’s disease
- 7 March 2007
- Published by Springer Nature in Journal of Neurology
- Vol. 254 (3) , 391-393
Presenilin 2 Ser130Leu mutation in a case of late-onset “sporadic” Alzheimer’s disease